CIK 0000310158
- Large accelerated filer
Merck & Co., Inc.
Sign in to watch- Ticker
- MRK
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- Operating
- EIN
- 221918501
- Phone
- +1 908-740-4000
- Business address
- 126 EAST LINCOLN AVENUE, P.O. BOX 2000, RAHWAY, NJ, 07065
- Former names
- Merck & Co. Inc., SCHERING PLOUGH CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $8,611,875
- in 1 filing
Net −$8,611,875. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-05-04 | Klobuchar Michael A EVP - Chief Strategy Officer | Option exercise | +885 | $87.10 | $77K | 15,774.93 |
| 2022-05-04 | Klobuchar Michael A EVP - Chief Strategy Officer | Shares withheld for taxes | −436 | $87.10 | $38K | 15,338.93 |
| 2022-05-04 | Klobuchar Michael A EVP - Chief Strategy Officer | Option exercise · Restricted Stock Unit | −885 | 1,772 | ||
| 2022-05-04 | LeCointe-Cephas Lisa SVP Chief Ethics & Com Officer | Option exercise | +813 | $87.10 | $71K | 3,942.78 |
| 2022-05-04 | LeCointe-Cephas Lisa SVP Chief Ethics & Com Officer | Shares withheld for taxes | −279 | $87.10 | $24K | 3,663.78 |
| 2022-05-04 | LeCointe-Cephas Lisa SVP Chief Ethics & Com Officer | Option exercise · Restricted Stock Unit | −813 | 1,629 | ||
| 2022-05-03 | Oosthuizen Johannes Jacobus SVP, U.S. Market | Grant or award · Stock Option (Right to Buy) | +21,359 | 21,359 | ||
| 2022-05-03 | Garay Arpa SVP Human Health Global Mktg. | Grant or award · Stock Option (Right to Buy) | +21,359 | 21,359 | ||
| 2022-05-03 | Williams David Michael EVP,Chief Info&Digital Officer | Grant or award · Stock Option (Right to Buy) | +21,359 | 21,359 | ||
| 2022-05-03 | Karachun Rita A Sr. VP Fince-Global Controller | Grant or award · Stock Option (Right to Buy) | +13,592 | 13,592 | ||
| 2022-05-03 | Karachun Rita A Sr. VP Fince-Global Controller | Grant or award · Restricted Stock Unit | +2,411 | 2,411 | ||
| 2022-05-03 | Zachary Jennifer EVP, General Counsel | Grant or award · Stock Option (Right to Buy) | +58,252 | 58,252 | ||
| 2022-05-03 | MIZELL STEVEN EVP, Chief HR Officer | Grant or award · Stock Option (Right to Buy) | +40,777 | 40,777 | ||
| 2022-05-03 | Li Dean Y Executive VP & President, MRL | Grant or award · Stock Option (Right to Buy) | +75,728 | 75,728 | ||
| 2022-05-03 | Litchfield Caroline EVP & CFO | Grant or award · Stock Option (Right to Buy) | +53,398 | 53,398 | ||
| 2022-05-03 | Klobuchar Michael A EVP - Chief Strategy Officer | Grant or award · Stock Option (Right to Buy) | +25,243 | 25,243 | ||
| 2022-05-03 | LeCointe-Cephas Lisa SVP Chief Ethics & Com Officer | Grant or award · Stock Option (Right to Buy) | +11,650 | 11,650 | ||
| 2022-05-03 | LeCointe-Cephas Lisa SVP Chief Ethics & Com Officer | Grant or award · Restricted Stock Unit | +2,067 | 2,067 | ||
| 2022-05-03 | DeLuca Richard R. EVP&Pres, Merck Animal Heallth | Grant or award · Stock Option (Right to Buy) | +58,252 | 58,252 | ||
| 2022-05-03 | Downing Cristal N Chief Comm. & Public Afrs Ofcr | Grant or award · Stock Option (Right to Buy) | +19,417 | 19,417 |
Page 35 of 42 · 823 trades